Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857) 13D and 13G filings for IGC Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-14 4:23 pm Unchanged | 2024-03-22 | 13D | IGC Pharma, Inc. IGC | Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857) | 13,823,529 18.300% | 0 (Unchanged) | Filing |
| 2024-05-21 9:20 pm Purchase | 2024-03-22 | 13D | IGC Pharma, Inc. IGC | Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857) | 13,823,529 18.300% | 13,823,529 (New Position) | Filing |